BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3906415)

  • 21. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
    O'Connor R; MacFarlane JK; Murray D; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of breast cancer by leukocyte adherence inhibition assay.
    Sanner T; Kotlar HK; Eker P; Brennhovd I; Host H; Jorgensen O
    Cancer Detect Prev; 1983; 6(4-5):443-50. PubMed ID: 6360351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
    Mounielou PM; Clemente F; Estival A; Ribet A
    Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):607-19. PubMed ID: 3526756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
    Lopez M; O'Connor R; MacFarlane JK; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):660-73. PubMed ID: 369585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
    Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
    Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
    Kalafut F; Cernák A
    Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
    Wagner T; Peschel U; Heydrich D; Ritter U
    Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
    Dubois AE; Thomson DM; Sutherland ME; Scanzano R
    Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
    Kubasova T; Pázmány T; Horváth M; Pál K; Köteles GJ
    Neoplasma; 1991; 38(1):63-8. PubMed ID: 2011211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the participation of the alpha-chain of the LFA-1 antigen in the phenomenon of lymphocyte adherence inhibition using ICO-11 monoclonal antibodies in vitro].
    Kharkevich DD; Baryshnikov AIu; Savel'eva EV; Polevaia EB; Kadagidze ZG
    Biull Eksp Biol Med; 1987 Dec; 104(12):711-3. PubMed ID: 3318954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tube LAI assay in diagnosis and monitoring of a cancer disease.
    Hasek M; Holán V; Kousalová M
    Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of the micromodified leukocyte adherence inhibition test in the diagnosis of breast cancer].
    Kharkevich DD; Sablikova IuA; Polevaia EB; Savinov AIu
    Lab Delo; 1985; (6):374-6. PubMed ID: 2413267
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition.
    Tanaka F; Sawada K; Yonemoto RH
    Gan; 1980 Oct; 71(5):589-95. PubMed ID: 7014342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of leukocyte adherence inhibition assay in early detection of breast cancer.
    Kovarík J; Lauerová L; Kudlicková Z; Ninger E; Zemanová D
    Arch Geschwulstforsch; 1981; 51(4):344-8. PubMed ID: 7032450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.